After Watershed Year, Pfizer Expects Revenue to Top $98B in ’22
Summary : Pfizer Chief Executive Officer Albert Bourla called 2021 a watershed year for the company. It posted $81.3 billion in revenue…
Summary : Pfizer Chief Executive Officer Albert Bourla called 2021 a watershed year for the company. It posted $81.3 billion in revenue…
Summary : EMA’s human medicines committe has recommended granting conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 / ritonavir) for…
KEYPOINTS: Pfizer announced that its oral antiviral cut the risk of hospitalization or death by 89% in an interim analysis of the…